AI algorithm can help identify high-risk heart patients: Study
The algorithm, known as Viz HCM, had previously been approved by the Food and Drug Administration (FDA) for the detection of HCM on an electrocardiogram (ECG).
The Mount Sinai study, published in the journal NEJM AI, assigns numeric probabilities to the algorithm's findings.
For example, while the algorithm might previously have said 'flagged as suspected HCM' or 'high risk of HCM,' the Mount Sinai study allows for interpretations such as, 'You have about a 60 percent chance of having HCM,' said Joshua Lampert, Director of Machine Learning at Mount Sinai Fuster Heart Hospital.
As a result, patients who had not previously been diagnosed with HCM may be able to get a better understanding of their individual disease risk, leading to a faster and more individualized evaluation, along with treatment to potentially prevent complications such as sudden cardiac death, especially in young patients.
'This is an important step forward in translating novel deep-learning algorithms into clinical practice by providing clinicians and patients with more meaningful information.
Clinicians can improve their clinical workflows by ensuring the highest-risk patients are identified at the top of their clinical work list using a sorting tool,' said Lampert, Assistant Professor of Medicine (Cardiology, and Data-Driven and Digital Medicine) at the Icahn School of Medicine at Mount Sinai.
HCM impacts one in 200 people worldwide and is a leading reason for heart transplantation.
However, many patients don't know they have the condition until they have symptoms and the disease may already be advanced.
'This study reflects pragmatic implementation science at its best, demonstrating how we can responsibly and thoughtfully integrate advanced AI tools into real-world clinical workflows,' said co-senior author Girish N Nadkarni, Chair of the Windreich Department of Artificial Intelligence and Human Health and Director of the Hasso Plattner Institute for Digital Health.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients
The US Food and Drug Administration (FDA) recently approved a medical device that could bring new hope to patients suffering from rheumatoid arthritis (RA), a chronic autoimmune condition often difficult to treat with conventional medications. Unlike standard therapies, the device harnesses the brain and nervous system to suppress the uncontrolled inflammation responsible for the disease. The SetPoint System is a small, inch-long implant surgically placed in the neck, wrapping around the vagus nerve, which is thought to be the longest nerve in the body. It delivers one minute of electrical stimulation per day, which research suggests can 'reset' the immune system and reduce crippling inflammation. Unlike most RA drugs that suppress the immune system and increase infection risk, this device works by re-educating the body's immune response. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Described on a recent episode of the American College of Rheumatology podcast as a 'true paradigm shift' in RA treatment, the SetPoint implant moves away from decades of reliance on pharmaceuticals, from gold salts to biologics. The FDA had granted it breakthrough designation last year to accelerate development and approval. The device represents an early example of bioelectronic medicine, which aims to control inflammation—a key factor in conditions including diabetes, heart disease, and cancer. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Clinical trials are already exploring vagus nerve stimulation for inflammatory bowel disease in children, lupus, multiple sclerosis, and Crohn's disease. In a yearlong randomized controlled trial involving 242 patients with a sham-treatment group, over half of participants using the implant alone achieved remission or experienced disease improvement. Joint pain and swelling decreased by 60% and 63%, respectively. However, the device's long-term safety and effectiveness outside clinical trials remain unknown, and the FDA requires post-marketing monitoring. Experts warn that surgery for implants can carry a risk of serious infections resistant to antibiotics. For Dawn Steiner, a 58-year-old speech pathologist and clinical trial participant, the implant has been transformative. Diagnosed with RA 15 years ago, she tried eight biologic drugs with limited success. 'Before the implant, the doctor would ask where I was in terms of pain on a scale of one to 10, and I would say I was living a six or seven,' she said. 'Now I'm about a two.' Live Events The SetPoint device stems from decades of research led by Dr. Kevin J. Tracey, neurosurgeon and president of the Feinstein Institutes for Medical Research at Northwell Health. Tracey co-founded SetPoint Medical and now serves as an adviser. He describes the vagus nerve as an 'on-off switch' for an overactive immune system. 'The brain can turn off inflammation as long as the vagus nerve is intact,' he said. 'It's like a brake system in your car.' Dr. David Chernoff, chief medical officer of SetPoint Medical, explained, 'Drugs find a pathway that contributes to damaging joints in RA patients and try to block it. What we're doing is completely different. We're re-educating the immune system through the brain to behave differently.' He added, 'we're not blocking the ability to fight off infection.' Tracey noted that some inflammation is necessary for healing wounds, fighting infections, and tissue repair. The device's price has not been disclosed, but a spokeswoman said it is designed to last 10 years and could cost less than a year of certain RA medications. Dr. Lou Bridges, chief of rheumatology at the Hospital for Special Surgery and NewYork-Presbyterian/Weill Cornell Medical Center, expressed cautious optimism. 'It's still early days. The proof will be in the pudding,' he said. 'I'm hoping they are correct, and this is a revolutionary new way to treat RA without drugs and without side effects. But I've heard this story before.' [With TOI inputs]
Indian Express
12 hours ago
- Indian Express
As sudden cardiac arrests become common in young people, experts urge the need for these medical tests before starting gym
Sudden cardiac arrest in seemingly fit individuals often results from undiagnosed heart conditions. Hence, before starting any gym or workout routine, experts recommend that certain tests be done to understand the health status. Doing so will also help you to understand if the body is ready for physical exertion, said Dr Manjusha Agarwal, senior consultant, internal medicine, Gleneagles Hospital, Parel, Mumbai. Particularly for individuals over 30, those with a family history of heart disease, or people who are just starting, or restarting, intensive physical activity like gym workouts, these tests can help to detect underlying heart conditions that may otherwise go unnoticed until they become life-threatening, said Dr Narander Singla, lead consultant, internal medicine, CK Birla Hospital, Delhi. Here's a breakdown and explanation of five tests that should be done 1. ECG (Electrocardiogram) An ECG records the electrical activity of the heart and helps detect arrhythmias (irregular heart rhythms), conduction blocks, or signs of prior silent heart attacks. 'While not definitive alone, it provides a good baseline for identifying abnormalities in heart rhythm or conduction that may become dangerous during strenuous activity,' said Dr Singla. 2. 2D Echo (Echocardiography) This is a non-invasive ultrasound of the heart that allows doctors to visualise the heart's structure and function. 'It is especially helpful in identifying conditions like Hypertrophic Cardiomyopathy (HCM), a thickening of the heart muscle that often goes undiagnosed and can lead to sudden cardiac arrest during intense physical exertion. It also helps assess valve function, chamber sizes, and overall heart pumping ability,' said Dr Singla. 3. TMT (Treadmill Test or Stress Test) A TMT evaluates how your heart performs under stress (exercise). It can help reveal issues like exercise-induced arrhythmias or restricted blood flow to the heart (which may not be evident at rest). 'This is especially useful for people who plan to do high-intensity workouts or weight training, as it simulates physical stress in a controlled setting,' said Dr Singla. 4. Cardiac biomarkers – Troponin & NT-proBNP These blood tests detect subtle damage or stress to the heart muscle. 'High-sensitivity troponin is a marker for silent myocardial injury, while NT-proBNP indicates stress or stretching of the heart walls. Elevated levels, even without symptoms, can be an early warning sign of cardiovascular disease,' said Dr Singla. 5. Hs-CRP and ESR (Inflammatory Markers) These markers can help detect systemic inflammation, which is a contributing factor in atherosclerosis (plaque buildup in arteries). High levels of high-sensitivity C-reactive protein (hs-CRP) are associated with an increased risk of heart attack and stroke, even in people with normal cholesterol. 6. Lipid Profile + HbA1c (Metabolic Health Tests) A lipid profile evaluates cholesterol and triglyceride levels, which are directly linked to cardiovascular risk. Dr Singla explained that HbA1c gives a picture of your average blood sugar levels over the past 3 months and helps detect prediabetes or diabetes, conditions that increase heart disease risk significantly. Together, they help assess metabolic syndrome, which is often silent but increases cardiac risk, said Dr Singla. Moreover, a vitamin D and B12 test helps to check if any deficiencies could affect energy, bone strength, and muscle function, said Dr Agarwal. 'These tests should be taken by the gym-goers without fail on a priority basis. Initiate any workout routine only after you get a go-ahead from the expert, after knowing the test results. Be attentive when it comes to your overall well-being,' said Dr Agarwal. Intense physical stress can unmask these problems, especially in people who may not have exercised in years or have underlying risks. Dr Agarwal noted that these tests are 'not luxury options', they are preventive screenings that could literally save lives. 'They offer a chance to catch conditions like HCM, arrhythmias, ischemic heart disease, or silent heart strain before a fatal event occurs,' said Dr Agarwal. DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.
Time of India
14 hours ago
- Time of India
How a one-minute jolt can offer hope to those with auto-immune disease
The US Food and Drug Administration (FDA) approved a medical device recently that offers new hope to patients incapacitated by rheumatoid arthritis (RA), a chronic condition often resistant to treatment and usually managed with medications. The device represents a radical departure from standard care, tapping the power of the brain and nervous system to tamp down the uncontrolled inflammation that leads to the debilitating autoimmune disease. The SetPoint System is an inch-long device surgically implanted into the neck, where it sits in a pod wrapped around the vagus nerve, which some scientists believe is the longest nerve in the body. The device electrically stimulates the nerve for one minute each day. The stimulation can turn off crippling inflammation and 'reset' the immune system, research has shown. Most drugs used to treat rheumatoid arthritis suppress the immune system, leaving patients vulnerable to serious infections. On a recent episode of the American College of Rheumatology podcast, the SetPoint implant was described as a 'true paradigm shift' in treatment of the disease, which until now has relied almost entirely on an evolving set of pharmaceutical interventions, from gold salts to biologics. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo The FDA designated the implant as a breakthrough last year to expedite its development and approval. It represents an early test of the promise of so-called bioelectronic medicine to modulate inflammation, which plays a key role in diseases including diabetes, heart disease and cancer. Clinical trials are already underway testing vagus nerve stimulation to manage inflammatory bowel disease in children, lupus and other conditions. Trials for patients with multiple sclerosis and Crohn's disease are also planned. In a yearlong randomised controlled trial of 242 patients that included a sham-treatment arm, over half of the participants using the SetPoint implant alone achieved remission or saw their disease recede. Measures of joint pain and swelling fell by 60% and 63% respectively. The device's long-term effectiveness and safety outside a clinical trial are not yet known. The FDA required post-marketing monitoring of patients and adverse events as part of the approval. Surgery involving implants can lead to serious infections resistant to antibiotics, experts noted. For Dawn Steiner, 58, a speech pathologist, who participated in the clinical trial, the implant has been a game changer. She was diagnosed with rheumatoid arthritis 15 years ago and has tried eight different biologic agents since then. 'Before the implant, the doctor would ask where I was in terms of pain on a scale of one to 10, and I would say I was living a six or seven,' she said. 'Now I'm about a two.' The SetPoint device is the product of decades of research spearheaded by Dr Kevin J Tracey, a neurosurgeon who is president and chief executive of the Feinstein Institutes for Medical Research at Northwell Health. Tracey co-founded SetPoint Medical, but now serves as an adviser. He describes the vagus nerve, which originates in the brain and travels to virtually all the organs of the body, as an 'on-off switch' for an overactive immune system. 'The brain can turn off inflammation as long as the vagus nerve is intact,' he said. 'It's like a brake system in your car.' Dr David Chernoff, chief medical officer of SetPoint Medical, said, 'Drugs find a pathway that contributes to damaging joints in RA patients and try to block it. What we're doing is completely different. We're re-educating the immune system through the brain to behave differently,' he added. As a result, he said, 'we're not blocking the ability to fight off infection.' The body needs some level of inflammation, Tracey said, to help heal wounds, fight infections and promote tissue repair. The price has not been disclosed, but a spokeswoman said it was designed to last for 10 years and would be less expensive than a year's worth of some rheumatoid arthritis drugs, which can be quite costly. One key question is whether the implant's effectiveness will wane over time, said Dr Lou Bridges, chief of the division of rheumatology at the Hospital for Special Surgery and NewYork-Presbyterian/Weill Cornell Medical Center. 'It's still early days. The proof will be in the pudding,' he said. 'I'm hoping they are correct, and this is a revolutionary new way to treat RA without drugs and without side effects. But I've heard this story before. ' nyt news service By: Dr David Chernoff, CMO, SetPoint Medical
